VLDLR and lung cancer: On the other hand, hsa‐miR‐99a‐5p promotes cisplatin sensitivity and induces apoptosis by suppressing Very Low‐Density Lipoprotein Receptor (VLDLR) expression in lung cancer (Lang et al. 2023).